suitable for imaging ocular melanomas after labelling with I23I,"'In, or ImTc.
Melanoma is the commonest primary malignancy of the eye. There are two areas of difficulty in the clinical diagnosis of the tumour in the uvea. On the one hand a small pigmented malignant melanoma may be difficult to distinguish from a benign naevus, a melanocytoma, or a carcinoma of the retinal pigment epithelium. On the other, it may not be easy to decide whether a non-pigmented mass lesion is an amelanotic melanoma, a choroidal haemangioma, or a metastasis.
Choroidal biopsy is technically possible but many small melanomas are too posterior for the procedure to be contemplated without undue risk of complications. Fluorescein angiography and ultrasound may help to strengthen the clinical diagnosis, and in centres specialising in ocular tumours some 98% of these lesions are diagnosed correctly by non-invasive investigations. ' The responses to monoclonal antibody with the avidin-biotin method were in several instances almost impossible to evaluate because of the melanin present in three of the tumours. Attempts to circumvent this problem by bleaching the cell impressions were unsatisfactory, since it was difficult to take the process to completion without damaging the tumour cells and causing a diffuse, non-specific peroxidase reaction. Non-specific staining of the background also added to the difficulty of interpretation.
Discussion
Cutaneous melanocytes located primarily in the epidermis are of neuroectodermal origin, whereas melanocytes of the uveal stroma appear to derive from the neural crest. This suggests that some differences as well as similarity in the antigenicity might be found, and the present limited study was undertaken to determine the extent to which monoclonal antibodies against Cutaneous Use is already made of radiolabelled monoclonal antibodies'6 to image metastases of skin melanomas at distant sites, and, given the sharing of tumour associated antigens, the same approach can be used to identify metastasis of uveal melanoma. This could be a major clinical application of the monoclonal antibodies.
Monoclonal antibodies of the type described could also be of value in histological diagnosis if combined with an immunofluorescent or immunoperoxidase technique. As such they would be particularly relevent to the differential diagnosis of nonpigmented spindle cell tumours in the eye.
